Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer

World Journal of Gastroenterology

Volumn 19, Issue 48, 2013, Pages 9425-9431

  Jiao, Xin ^a   Lu, Hong Jun ^a   Zhai, Mi Mi ^b   Tan, Zhi Jun ^c   Zhi, Hai Ning ^a   Liu, Xiao Man ^a   Liu, Chen Hao ^a   Zhang, Da Peng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

^c TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Gastric cancer; Kallikrein gene 10; Prognostic biomarkers; Survival analysis

Indexed keywords

MESSENGER RNA; OXALIPLATIN; RNA;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KALLIKREIN GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH CANCER; TUMOR INVASION;

GASTRIC CANCER; KALLIKREIN GENE 10; PROGNOSTIC BIOMARKERS; SURVIVAL ANALYSIS;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84891409287     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i48.9425     Document Type: Article

References (31)

1. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010; 31: 100-110 [PMID: 19934210 DOI: 10.1093/carcin/ bgp263]
2. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004; 90: 2157-2166 [PMID: 15150609]
3. Yin XD, Huang WB, Lü CY, Zhang L, Wang LW, Xie GH. A preliminary study on correlations of triple-phase multi-slice CT scan with histological differentiation and intratumoral microvascular/lymphatic invasion in gastric cancer. Chin Med J (Engl) 2011; 124: 347-351 [PMID: 21362331]
4. Zhang SW, Lei ZL, Li GL, Zou XN, Zhao P, Chen WQ. A report of cancer incidence and mortality from 34 cancer registries in China. Zhongguo Aizheng 2010; 19: 356-365 [DOI:10.1093/occmed/kqs01]
5. Liu J, Chen L. Current status and progress in gastric cancer with liver metastasis. Chin Med J (Engl) 2011; 124: 445-456 [PMID: 21362349]
6. Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 2002; 48: 1198-1205 [PMID: 12142373]
7. Borgoño CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 4: 876-890 [PMID: 15516960 DOI: 10.1038/nrc1474]
8. Bayani J, Paliouras M, Planque C, Shan SJ, Graham C, Squire JA, Diamandis EP. Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer. Mol Oncol 2008; 2: 250-260 [PMID: 19383346 DOI: 10.1016/ j.molonc.2008.07.001]
9. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Bellino R, van Gramberen M, de Bruijn H, Henrik A, Stenman UH, Massobrio M, van der Zee AG, Vergote I, Diamandis EP. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res 2003; 63: 807-811 [PMID: 12591730]
10. Shan SJ, Scorilas A, Katsaros D, Diamandis EP. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects. Br J Cancer 2007; 96: 362-372 [PMID: 17242704 DOI: 10.1038/sj.bjc.6603556]
11. Yousef GM, Borgoño CA, Scorilas A, Ponzone R, Biglia N, Iskander L, Polymeris ME, Roagna R, Sismondi P, Diamandis EP. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis. Br J Cancer 2002; 87: 1287-1293 [PMID: 12439719]
12. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995; 45: 729-744 [PMID: 7538236 DOI: 10.1016/S0090-4295(99)80076-4]
13. Avgeris M, Papachristopoulou G, Polychronis A, Scorilas A. Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions. Clin Proteomics 2011; 8: 5 [PMID: 21906360 DOI: 10.1186/1559-0275-8-5]
14. Kishi T, Grass L, Soosaipillai A, Scorilas A, Harbeck N, Schmalfeldt B, Dorn J, Mysliwiec M, Schmitt M, Diamandis EP. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res 2003; 63: 2771-2774 [PMID: 12782581]
15. Borgoño CA, Grass L, Soosaipillai A, Yousef GM, Petraki CD, Howarth DH, Fracchioli S, Katsaros D, Diamandis EP. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Cancer Res 2003; 63: 9032-9041 [PMID: 14695222]
16. Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A. Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemost 2004; 91: 180-186 [PMID: 14691584]
17. Talieri M, Li L, Zheng Y, Alexopoulou DK, Soosaipillai A, Scorilas A, Xynopoulos D, Diamandis EP. The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. Br J Cancer 2009; 100: 1659-1665 [PMID: 19367279 DOI: 10.1038/sj.bjc.6605033]
18. White NM, Chow TF, Mejia-Guerrero S, Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis A, Yousef GM. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer. Br J Cancer 2010; 102: 1244-1253 [PMID: 20354523 DOI: 10.1038/ sj.bjc.6605634]
19. Ogawa K, Utsunomiya T, Mimori K, Tanaka Y, Tanaka F, Inoue H, Murayama S, Mori M. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma. Br J Cancer 2004; 91: 282-286 [PMID: 15199388]
20. Dasgupta S, Tripathi PK, Qin H, Bhattacharya-Chatterjee M, Valentino J, Chatterjee SK. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Oral Oncol 2006; 42: 306-316 [PMID: 16321566 DOI: 10.1016/j.oraloncology.2005.08.007]
21. Luo LY, Diamandis EP, Look MP, Soosaipillai AP, Foekens JA. Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance. Br J Cancer 2002; 86: 1790-1796 [PMID: 12087468 DOI: 10.1038/sj.bjc.6600323]
22. Olkhov-Mitsel E, Van der Kwast T, Kron KJ, Ozcelik H, Briollais L, Massey C, Recker F, Kwiatkowski M, Fleshner NE, Diamandis EP, Zlotta AR, Bapat B. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. Epigenetics 2012; 7: 1037-1045 [PMID: 22874102 DOI: 10.4161/epi.21524]
23. Luo LY, Bunting P, Scorilas A, Diamandis EP. Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin Chim Acta 2001; 306: 111-118 [PMID: 11282101 DOI: 10.1016/ S0009-8981(01)00401-6]
24. Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. J Gastroenterol Hepatol 2006; 21: 1596-1603 [PMID: 16928223 DOI: 10.1111/ j.1440-1746.2006.04228.x]
25. Inoue Y, Yokobori T, Yokoe T, Toiyama Y, Miki C, Mimori K, Mori M, Kusunoki M. Clinical significance of human kallikrein7 gene expression in colorectal cancer. Ann Surg Oncol 2010; 17: 3037-3042 [PMID: 20544292 DOI: 10.1245/s10434-010-1132-y]
26. Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 2001; 84: 643-650 [PMID: 11237385 DOI: 10.1054/bjoc.2000.1649]
27. Ramachandran R, Eissa A, Mihara K, Oikonomopoulou K, Saifeddine M, Renaux B, Diamandis E, Hollenberg MD. Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14. Biol Chem 2012; 393: 421-427 [PMID: 22505524 DOI: 10.1515/ hsz-2011-0251]
28. Hollenberg MD, Oikonomopoulou K, Hansen KK, Saifeddine M, Ramachandran R, Diamandis EP. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol Chem 2008; 389: 643-651 [PMID: 18627296 DOI: 10.1515/BC.2008.077]
29. Ramsay AJ, Reid JC, Adams MN, Samaratunga H, Dong Y, Clements JA, Hooper JD. Prostatic trypsin-like kallikreinrelated peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinaseactivated receptors (PARs). Biol Chem 2008; 389: 653-668 [PMID: 18627286 DOI: 10.1515/BC.2008.078]
30. Gratio V, Beaufort N, Seiz L, Maier J, Virca GD, Debela M, Grebenchtchikov N, Magdolen V, Darmoul D. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am J Pathol 2010; 176: 1452-1461 [PMID: 20056842 DOI: 10.2353/ajpath.2010.090523]
31. Gratio V, Loriot C, Virca GD, Oikonomopoulou K, Walker F, Diamandis EP, Hollenberg MD, Darmoul D. Kallikreinrelated peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am J Pathol 2011; 179: 2625-2636 [PMID: 21907696 DOI: 10.1016/ j.ajpath.2011.07.016]